ARTICLE | Company News
Genaera other research news
October 1, 2001 7:00 AM UTC
GENR received an award of up to $1.7 million from the Cystic Fibrosis Foundation subsidiary Cystic Fibrosis Foundation Therapeutics Inc. to develop Lomucin. The oral gob-5 channel blocker inhibits exc...